BW A256C, A NOVEL CLASS IC ANTIARRHYTHMIC AGENT - CARDIOVASCULAR ACTIONS AND PHARMACOKINETICS IN VOLUNTEERS

被引：0
|
作者：
CROOKS, RJ
BERGMAN, G
WILKES, NPF
METCALFE, JM
JEWITT, DE
机构：
[1] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,DEPT CARDIAC,LONDON SE5 8RX,ENGLAND
来源：
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1987年 / 10卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：992 / 992
页数：1
相关论文
共 15 条
  • [1] BW A256C, A CHEMICALLY NOVEL CLASS-1 ANTIARRHYTHMIC AGENT - A COMPARISON OF INVITRO AND INVIVO ACTIVITY WITH OTHER CLASS-1 ANTIARRHYTHMIC AGENTS
    ALLAN, G
    DONOGHUE, S
    FOLLENFANT, MJ
    SAWYER, DA
    BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (02) : 333 - 343
  • [2] EFFECTS OF BW A256C, A NOVEL CLASS-1 ANTIARRHYTHMIC AGENT, ON MAXIMUM RATE OF DEPOLARIZATION OF CARDIAC ACTION-POTENTIALS INVITRO - FREQUENCY, USE, AND VOLTAGE DEPENDENCE
    DONOGHUE, S
    PAYNE, PN
    ALLAN, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (01) : 12 - 18
  • [3] ELECTROPHYSIOLOGICAL EFFECTS OF BW-A256C (NOVEL CLASS-I ANTIARRHYTHMIC AGENT) - INVITRO AND INVIVO STUDIES
    ROUET, R
    VINCENT, A
    WERQUIN, S
    LIBERSA, C
    DUPUIS, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (05) : 364 - 365
  • [4] CARDIOVASCULAR ACTIVITY OF A CLASS-IC ANTIARRHYTHMIC AGENT, SC-35135
    FREDERICK, L
    STAMM, M
    HATLEY, F
    GARTHWAITE, S
    FEDERATION PROCEEDINGS, 1986, 45 (04) : 803 - 803
  • [5] TOLERANCE AND PHARMACOKINETICS OF A NOVEL OPIOID PEPTIDE BW 443C IN HEALTHY-VOLUNTEERS
    POSNER, J
    DEAN, K
    JEAL, S
    MOODY, G
    PECK, AW
    RUTTER, G
    TELEKES, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (02) : P266 - P266
  • [6] CPU86017: A novel class III antiarrhythmic agent with multiple actions at ion channels
    Dai, De-Zai
    CARDIOVASCULAR DRUG REVIEWS, 2006, 24 (02): : 101 - 115
  • [7] L-702,958 A NOVEL CLASS-III ANTIARRHYTHMIC AGENT IN HEALTHY-VOLUNTEERS
    PIGUET, V
    APPENZELLER, M
    BUCLIN, T
    NASRATULLAH, M
    KAPPENBERGER, L
    MALMSTROM, K
    GOLDBERG, M
    PORRAS, A
    GREBER, T
    BIOLLAZ, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 138 - 138
  • [8] AN ELECTROPHYSIOLOGICAL COMPARISON OF A NOVEL CLASS IC ANTIARRHYTHMIC AGENT, NIK-244 (ETHACIZIN) AND FLECAINIDE IN CANINE VENTRICULAR MUSCLE
    SATOH, H
    ISHII, M
    HASHIMOTO, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (03) : 827 - 832
  • [9] A DOSE-RANGING STUDY OF UK-68,798, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT, IN NORMAL VOLUNTEERS
    GEMMILL, JD
    HOWIE, CA
    MEREDITH, PA
    KELMAN, AW
    RASMUSSEN, HS
    HILLIS, WS
    ELLIOTT, HL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (04) : 429 - 432
  • [10] Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs
    Knobloch, K
    Brendel, J
    Rosenstein, B
    Bleich, M
    Busch, AE
    Wirth, KJ
    MEDICAL SCIENCE MONITOR, 2004, 10 (07): : BR221 - BR228
12